Zoetis Inc. (zts)
ZTS Earnings
Public earnings and growth snapshot for Zoetis Inc.. Full earnings calendars, surprises, and multi-year history are available in Vest Terminal.
| Earnings growth (YoY) | 1.2% |
| Revenue growth (YoY) | -0.2% |
| Trailing P/E | 11.90 |
| Forward P/E | 10.96 |
| Last price | $71.61 |
| Market cap | $29.59B |
Start Free — open ZTS in Vest Terminal
Access live data, filings, ownership, and analysis for Zoetis Inc..
Zoetis Inc. FAQ
What does Zoetis Inc. (ZTS) do?
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationall…
What is ZTS's P/E ratio?
Zoetis Inc. has a trailing P/E of 11.90× based on publicly available market data.
Does ZTS pay a dividend?
Indicated dividend yield: 2.9%. Confirm ex-dates and payout history in Vest Terminal.
What sector is ZTS in?
Zoetis Inc. is classified in Healthcare (Drug Manufacturers - Specialty & Generic) on NYQ.
What is ZTS's market capitalization?
Approximate market cap: $29.59B.
What are the main risks for ZTS?
Key risks include negative revenue growth, among factors on this page.
What are the strengths of ZTS?
Potential positives include earnings growth of 1.2% year-over-year, return on equity near 64.9% — efficient use of shareholder capital.
Where can I get analyst estimates for ZTS?
Public analyst price targets and consensus for Zoetis Inc. are on the free /stocks/zts/estimates page. Deeper estimate history and models are available in Vest Terminal.